LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,955,374 | +9.1% | 207,762 | +12.1% | 0.00% | +33.3% |
| Q2 2023 | $12,791,190 | +206.2% | 185,299 | +113.9% | 0.00% | +200.0% |
| Q1 2023 | $4,177,346 | -26.7% | 86,631 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $5,701,912 | +27.1% | 114,221 | +3.9% | 0.00% | +100.0% |
| Q3 2022 | $4,487,000 | -4.6% | 109,981 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $4,702,000 | +117.5% | 85,497 | +43.7% | 0.00% | 0.0% |
| Q1 2022 | $2,162,000 | -20.0% | 59,496 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $2,702,000 | +27.0% | 57,949 | +15.9% | 0.00% | 0.0% |
| Q2 2020 | $2,128,000 | – | 50,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |